EULAR Press Releases

Read the latest:

-EULAR: Significant Increase for Impact Factor of Annals of The Rheumatic Diseases (ARD), The Eular Journal, Reflects rapidly Improving Quality of Rheumatology Research

-Ankylosing Spondylitis (AS): Becoming a mother despite having a rheumatic disease? Study of Infants and Young Children Shows that Offspring Develop Normally

BioMed Alliance initiative

It is time to coordinate health research efforts across Europe through the implementation of a European Health Research Council.

New: EULAR COVID-19 Repositories for patients and clinicians

Find EULAR guidances and useful resources on COVID-19 outbreak to obtain the best possible recommendations and support:

- RMDs and COVID-19 repository for Clinicians

- RMDs and COVID-19 repository for Patients

EULAR Recommendations 2020

Read the latest:

- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

EULAR Feedback on the EU Pharmaceuticals Strategy Roadmap

EULAR welcomes the initiative of the European Commission to modernise and update the existing regulatory framework for pharmaceutical products in the European Union. 

Registration to EULAR 2020 E-CONGRESS

Join our major event in the world of Rheumatology!

Registration to the EULAR E-CONGRESS 2020 remains open. 
Register and get your access to the scientific sessions until 31 August 2020!

EULAR Centres of Excellence Call

EULAR invites centres of rheumatology research in Europe to apply for recognition as "EULAR Centre of Excellence in Rheumatology", this time for the period 2020 - 2025.

The EULAR - COVID-19 Reporting Database for rheumatologists and other clinicians

To report cases of COVID-19 in patients with RMDs